[Effect of tavromycetin of the formation of antibodies in laboratory animals].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000917:Antibody Formation / Q000187:drug effects*; D000937:Antigen-Antibody Reactions; D000941:Antigens; D001379:Azathioprine / Q000494:pharmacology; D004357:Drug Synergism; D006460:Hemolysin Proteins / Q000037:antagonists & inhibitors; D007166:Immunosuppressive Agents; D015122:Mercaptopurine / Q000494:pharmacology; D051379:Mice; D011817:Rabbits; D016038:Skin Transplantation; D014181:Transplantation Immunology / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000941:Antigens; D006460:Hemolysin Proteins; D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D001379:Azathioprine
Vliianie tavromitsetina na obrazovanie antitel u laboratornykh zhivotnykh.